Summary The occurrence of aberrations involving chromosomes 11 and 17 in malignant tissues of breast cancer patients has not yet been studied systematically. Using fluorescence in situ hybridisation (FISH) with centromere-specific probes, we determined chromosome 11 Ascites and pleural effusion cells were washed twice in PBS and fixed as described above. Biotin-labelled a-satellite probes specific for the centromeric regions of human chromosomes 11 (probe DIIZI) and 17 (probe D17Z1) were obtained from Oncor (Gaithersburg, MD, USA). The in situ hybridisation procedure followed the protocol described previously (Escudier et al., 1993 (Hopman et al., 1988) . All cells in a field except those with the typical morphology of granulocytes were evaluated. As controls, FISH of chromosomes 11 and 17 was concomitantly performed with peripheral blood mononuclear cells from two healthy donors, with bone marrow cells from a patient with melanoma (without marrow involvement by histology) and with pleural effusion cells from a patient witih reactive pleuritis. No significant differences in FISH results between these tissues were noted in two separate experiments.
Metaphase karyotyping of solid tumours is of great value in defining chromosomal features potentially responsible for tumorigenesis, but classical cytogenetics is extremely laborious and has been hampered by the usually low mitotic index of tumour cells in vitro. Targeting of specific chromosomal regions in interphase nuclei by fluorescence in situ hybridisation (FISH) (Cremer et al., 1986; Pinkel et al., 1986) offers the possibility of detecting chromosomal aberrations in a large number of tumour cells independent of their proliferative capacity. FISH has revealed new insights into tumour biology (reviewed by Le Beau, 1993; Wolman, 1994) and, as a rapid and inexpensive technique, might gain importance in clinical oncology.
Several reports describe aberrations of chromosomes 11 and 17 in breast carcinoma, which harbour genes of causative importance for tumorigenesis and propagation (reviewed in Devilee and Cornelisse, 1994 Ascites and pleural effusion cells were washed twice in PBS and fixed as described above. Biotin-labelled a-satellite probes specific for the centromeric regions of human chromosomes 11 (probe DIIZI) and 17 (probe D17Z1) were obtained from Oncor (Gaithersburg, MD, USA). The in situ hybridisation procedure followed the protocol described previously (Escudier et al., 1993 .5 (Figure la-c (Dutrillaux et al., 1990; Takita et al., 1992; Zafrani et al.. 1992; Winqvist et al., 1993; Kallioniemi et al., 1994; Kirchweger et al., 1994) , and therefore our interest was focused on these chromosomes.
Using centromeric probes, we detected cell populations with abnormalities of chromosomes 11 and 17 in all specimens from the 30 patients studied. Previous FISH studies provided only indirect information on centromeric copy numbers of chromosome 17 in breast cancer cells Matsumura et al., 1992) . The data presented here support the hypothesis raised by recent investigations that breast tumours with a diploid karyotype may occur at a much lower frequency than previously assumed (Beerman et al.. 1991; Gnant et al., 1993; Kotliar et al., 1993) .
It should be taken into account that FISH with probes for centromeric sequences may point to not only numerical, but also structural chromosomal aberrations, particularly rearrangements, which have been reported to occur frequently in juxtacentromeric regions in breast cancer cells (Dutrillaux et al., 1990 ). Thus. translocation or loss of a part of the centromeric region might be the reason for hybridisation signals appearing relatively small, as indeed observed in several specimens ( Figure Ic) . (Dutrillaux et al.. 1991; Devilee and Cornelisse. 1994) . Our finding of varying signal number distributions for both chromosomes was indicative of inter-and intra-tumour heterogeneity. mostly to a marked extent (Table I ). This is highlighted by the finding of rare 'giant nuclei' with high copy numbers of centromeres ( Figure Ic) . In a previous study. the presence of rare breast cancer cells with highly elevated DNA contents probably resulting from multiple endoreduplication events was observed by DNA image cytometry (Cornelisse and Van Driel-Kulker. 1985) .
No correlation was found between patient age, histological tumour grade. tumour stage and aneuploidy pattern by FISH. Likewise. we could not define subpopulations which might preferentially disseminate to positive axillary lymph nodes with the FISH probes used here. Rather, it may be assumed that tumour heterogeneity evolves in a similar way in both primary tumour and metastatic lesions. Together. these findings suggest that acquirement of genetic instability leading to clonal diversity is an early event, in agreement with previous reports (Heim et al., 1988; Dutrillaux et al., 1991; Shay et al., 1993) . To determine if particular features defined by FISH in early-stage primary tumours will indicate risk of relapse, more patients will be investigated prospectively.
Cells from one pleural effusion and two ascites were difficult to interpret as reactive or malignant by cytology, but populations with aneuploidies were identified by FISH. Thus, the addition of FISH allowed for the unequivocal identification of those specimens as being malignant. Metaphase preparations from the two ascites specimens revealed complex karyotypes confirming the FISH results. The finding that all primary and metastatic breast cancer specimens appear to exhibit chromosomal changes by FISH implies that tumour cell identification might be improved by the addition of FISH. In unclear effusions, this would be a major contribution because other techniques such as DNA ploidy measurement or immunocytochemistry were shown to lack absolute sensitivity and or specificity (Diaz-Arias et al., 1993; Baars et al., 1994; Banks et al., 1994; Rodriguez de Castro et al.. 1994) . In a similar approach, FISH of bladder wash specimens was successfully performed to detect malignant cells of transitional cell cancer (Cajulis et al., 1994) .
However, it remains to be established whether FISH screening is superior to immunostaining for the detection of breast tumour cells in bone marrow or stem cell harvests (Brugger et al.. 1994 : Menard et al.. 1994 .
